Literature DB >> 29631799

Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.

Magalie P Tardy1, Ilaria Di Mauro2, Nathalie Ebran3, Sadal Refae4, Alexandre Bozec5, Karen Benezery6, Frédéric Peyrade1, Joel Guigay1, Anne Sudaka-Bahadoran7, Cécile Badoual8, Florence Pedeutour2, Esma Saada-Bouzid9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29631799     DOI： 10.1016/j.oraloncology.2018.04.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  6 in total

1.  A mismatch repair-deficient and HPV-negative anorectal squamous cell carcinoma.

Authors:  Kun Jiang; Brian Martens; Logan Meyer; Kim Truong; Gregory Y Lauwers
Journal:  Virchows Arch       Date:  2019-02-07       Impact factor: 4.064

Review 2.  Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review).

Authors:  Annette Affolter; Johann Kern; Karen Bieback; Claudia Scherl; Nicole Rotter; Anne Lammert
Journal:  Int J Oncol       Date:  2022-06-01       Impact factor: 5.884

3.  Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.

Authors:  Jissy Vijo Poulose; Cessal Thommachan Kainickal
Journal:  World J Clin Oncol       Date:  2022-05-24

Review 4.  Predictive factors in the treatment of oral squamous cell carcinoma using PD-1/PD-L1 inhibitors.

Authors:  Antian Gao; Xiao Pan; Xudong Yang; Zitong Lin
Journal:  Invest New Drugs       Date:  2021-02-16       Impact factor: 3.850

Review 5.  Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.

Authors:  Hui-Ching Wang; Tsung-Jang Yeh; Leong-Perng Chan; Chin-Mu Hsu; Shih-Feng Cho
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

6.  Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer.

Authors:  Yueming Zhang; Anqi Lin; Yonghe Li; Weimin Ding; Hui Meng; Peng Luo; Jian Zhang
Journal:  Front Cell Dev Biol       Date:  2020-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.